Kaydee Shiraishi
Family Medicine · Las Vegas, NVNPI 1669143871
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,111 of the $3,861 with a category attached, or 80.6%. It is spread thinly across 24 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,179 and has fallen 84.8% since, to $332 in 2025.
Across 138 payments — averaging $27.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$913
- Novo Nordisk$448
- Corcept Therapeutics$393
- Lucid Diagnostics Inc.$227
- Pfizer$222
- AstraZeneca$183
- plus $1K from 18 others
What the payments were for
- Consulting fees$75019%
- Food & beverage$3,11181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 3 | $913 |
| Novo Nordisk | 30 | $448 |
| Corcept Therapeutics | 13 | $393 |
| Lucid Diagnostics Inc. | 6 | $227 |
| Pfizer | 11 | $222 |
| AstraZeneca | 6 | $183 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $177 |
| Amgen | 7 | $169 |
| Bayer | 5 | $168 |
| Optinose US, Inc. | 8 | $137 |
| Almatica Pharma LLC | 6 | $130 |
| Daiichi Sankyo Inc. | 6 | $115 |
| Lilly USA, LLC | 8 | $115 |
| Boehringer Ingelheim | 6 | $110 |
| Organon | 5 | $86 |
| GSK | 2 | $59 |
| Novartis | 2 | $40 |
| Mannkind Corporation | 2 | $37 |
| AbbVie | 2 | $35 |
| Viiv Healthcare Company | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Exact Sciences | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$119
- Kerendia$108
How this compares
$3,861 in reported general payments places this provider in the 85th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $701 |
| Methylprednisolone | 47 | $310 |
| Duloxetine Hcl | 15 | $289 |
| Azithromycin | 39 | $233 |
| Amlodipine Besylate | 20 | $201 |
| Tizanidine Hcl | 32 | $162 |
| Atorvastatin Calcium | 21 | $156 |
| Losartan Potassium | 11 | $144 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $119 |
| Gabapentin | 13 | $77 |
| Alendronate Sodium | 12 | $75 |
| Fluticasone Propionate | 11 | $70 |
| Cephalexin | 12 | $53 |
| Prednisone | 15 | $48 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.